EUVIMED · CrossrefJournal
Journal of Enzyme Inhibition and Medicinal Chemistry
ISSN 1475-6366 · Informa UK Limited
Latest articles
Discovery of novel N-(prop-2-yn-1-yl)-1,2,3,4-tetrahydronaphthalen-1-amine derivatives as MAO-B inhibitors for the treatment of Parkinson’s disease
Identification of a peptide inhibitor disrupting the PCSK9-LDLR interaction via pharmacophore-based virtual screening, molecular dynamics simulations and in vitro/vivo evaluation
Diethyl Phthalate (DEP) as a potential osteosarcoma risk factor: a multi-omics study integrating network Toxicology, single-cell RNA sequencing, and molecular docking
Synthetic strategies and therapeutic insights into FDA-approved indole-containing drugs
Design, synthesis and antiproliferative activity of oxadiazole derivatives as potent glycogen synthase kinase-3/histone deacetylase 6 dual inhibitors
Discovery of novel coumarin-containing triazolo[1,5-a]pyrimidine derivatives as potent ABCB1 inhibitor for modulation of multidrug resistance
Reactive oxygen species (ROS) research in drug discovery and drug delivery: Can the medium Be a Trojan Horse disguised as something benign?
Application of 18 β -glycyrrhetinic acid Fluorescent probes in cell imaging
Screening of peptide inhibitors targeting YAP-TEAD4 interaction: affinity evaluation and anti-AML cell activity
PROTACs in cancer therapy: targeted degradation of GPX4, PARP and epigenetic regulators
Mislocalisation of FLT3-ITD receptor contributes to MV4-11 leukaemia cell resistance to antibody-drug conjugate
In vitro screening of compounds for targeting gastric cancer with Y220C p53 mutation: a molecule combining zinc chelation and a Michael acceptor drives CDKN1 and BBC3 expression to restore a p53-dependent cytotoxicity
Synthesis and structure-activity relationship study of a library of 1-substituted [1,2,4]triazolo[4,3- a ]quinolines as valuable chemical probes for paraxonase-2 (PON2)
Discovery of ferulic acid carbamate derivatives as dual-targeting agents of BuChE and Nrf2 for Alzheimer’s disease
2 H -pyrazolo[3,4- d ]pyrimidin-4-amine derivatives as novel selective fibroblast growth factor receptor 2 (FGFR2) inhibitors
Expression of Concern
Radioiodinated compound FJR01: a novel P2X7R-targeted SPECT tracer for visualizing glioma-associated microglia/macrophages in a rat glioblastoma model
Discovery of azaindole/indole-fused pyrimidine tetracyclic scaffolds as novel potent CDK7 inhibitors
Pharmacological advances in Candida auris : emerging antifungal mechanisms and next-generation therapeutic strategies
Design, synthesis, and biological evaluation of tyrcinnamine derivatives as bactericides
Mechanisms of traditional Chinese medicine in enhancing the efficacy and reducing the toxicity of immune checkpoint inhibitors via regulation of the tumor microenvironment and gut microbiota
Targeting ALDH7A1 with covalent inhibitors reveals new chemical space for prostate cancer therapy
Flavonoids from Elsholtzia ciliata restore redox electron flow and metabolic signaling via PTP1B inhibition in muscle and liver cells
Structural optimization of CHI3L1 inhibitors with improved pharmacokinetics and functional activity in 3D glioblastoma models
Cadmium inhibits hSMUG1-mediated uracil excision: quantitative analysis and mitigation by Ganoderma lucidum extracts
Design and Pictet–Spengler enabled synthesis of carboxamide-substituted imidazo[1,2- a ]quinoxalines as dual EGFR and tubulin targeting anticancer agents
Shikonin suppresses diffuse large B-cell lymphoma progression by inducing ferritinophagy and ferroptosis via lncRNA ADPGK-AS1 downregulation
Systematic identification of bacterial neuraminidase inhibitors from Psoralea corylifolia using ultrafiltration-UPLC-Q-Orbitrap-MS and molecular dynamics
Targeting the BMX in cancer: molecular mechanisms and emerging therapeutic strategies
Lidocaine enhances antitumor effects of sorafenib and GW5074 in colorectal cancer cells
EUVIMED